2 ArticlesMylan
1 / 1
Strides Gets a $30m Escrow Payout After Settling with Mylan for $70m for Regulatory Issues
In the latest filing with the exchange, Strides Shasun has settled with Mylan for about $70 million for Regulatory and General Claims on the $1.75 ...
EMA agrees to review Mylan and Biocon’s Regulatory Submission for proposed biosimilar Pegfilgrastim
European Medical Agency has accepted the submission for the review of the biosimilar Pegfilgrastim co-developed by Mylan & Biocon. The proposed ...
